Abstract
Endometriosis is a chronic, debilitating disease, associated with pelvic pain and infertility. Recent epidemiological studies suggest that women with endometriosis are at increased risk for ovarian cancer. Although the causative factors for both endometriosis and ovarian cancer remain largely unknown, several similarities between the proposed etiology of ovarian cancer and the observed pathophysiology of endometriosis have been reported. MUC1 glycoprotein is present in endometriotic lesions and overexpressed in epithelial ovarian tumors. We are currently studying immunity to MUC1 antigen in newly emerging preclinical models for endometriosis and ovarian cancer and exploring the potential for immune therapy/prevention with MUC1 in both diseases.
Similar content being viewed by others
References
Gendler SJ, Lancaster CA, Taylor-Papadimitriou J, et al: Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin. J Biol Chem 1990;265:15286–15293.
Hanisch FG, Muller S: MUC1: the polymorphic a of a human mucin. Glycobiology 2000;10: 439–449.
Burchell JM, Mungul A, Taylor-Papadimitriou J: O-linked glycosylation in the mammary gland: changes that occur during malignancy. J Mammary Gland Biol Neoplasia 2001;6:355–364.
Beum PV, Singh J, Burdick M, Hollingsworth MA, Cheng PW: Expression of core 2 beta-1,6-N-acetylglu-cosaminyltransferase in a human pancreatic cancer cell line results in altered expression of MUC1 tumor-associated epitopes. J Biol Chem 1999;274:24641–24648.
Barnd DL, Lan MS, Metzgar RS, Finn OJ: Specific, major hitocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells. Proc Natl Acad Sci USA 1989;86: 7159–7163.
Fontenot JD, Mariappan SV, Catasti P, Domenech N, Finn OJ, Gupta G: Structure of a tumor associated antigen containing, a tandemly repeated immunodominant epitope. J Biomol Struct Dyn 1995;13:245–260.
Dunn GP, Old LJ, Schreiber RD: The three Es of cancer immunoediting. Annu Rev Immunol 2004;22:329–360.
Boman F, Buisine MP, Wacrenier A, Querleu D, Aubert JP, Porchet N. Mucin gene transcripts in benign and borderline mucinous tumours of the ovary: an in situ hybridization study. J Pathol 2001;193339–344.
Cao Y, Schlag PM, Karsten U: Immunodetection of epithelial mucin (MUC1, MUC3) and mucin-associated glycotopes (TF, Tn, and sialosyl-Tn) in benign and malignant lesions of colonic epithelium: apolar localization corresponds to malignant transformation. Virchows Arch 1997;431: 159–166.
Cao Y, Karsten U, Otto G, Bannasch P: Expression of MUC1, Thomsen-Friedenreich antigen, Tn, sialosyl-Tn, and alpha2,6-linked sialic acid in hepatocellular carcinomas and preneoplastic hepatocellular lesions. Virchows Arch 1999;434: 503–509.
Arul GS, Moorghen M, Myerscough N, Alderson DA, Spicer RD, Corfield AP: Mucin gene expression in Barrett's oesphagus: an in situ hybridisation and immuno-histochemical study. Gut 2000;47:753–761.
reis CA, David L, Correa P, et al: Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression. Cancer Res 1999;59: 1003–1007.
Lopez-Ferrer A, Curull V, Barranco C, et al: Mucins as differentiation markers in bronchial epithelium. Squamous cell carcinoma and adenocarcinoma display similar expression patterns. Am J Respir Cell Mol Biol 2001;24:22–29.
Jarrard JA, Linnoila RI, Lee H, Steinberg SM, Witschi H, Szabo E: MUC1 is a novel marker for the type II pneumocyte lineage during lung carcinogenesis. Cancer Res 1998;58:5582–5589.
Copin MC, Devisme L, Buisine MP, et al: From normal respiratory mucosa to epidermoid carcinoma: expression of human mucin genes. Int J Cancer 2000;86: 162–168.
Buisine MP, Desreaumaux P, Letertre E, et al: Mucin gene expression in intestinal epithelial cells in Crohn's disease. Gut 2001;49: 544–551.
Masaki Y, Oka M, Ogura Y, et al: Sialylated MUC1 mucin expression in normal pancreas, benign pancreatic lesions, and pancreatic ductal adenocarcinoma. Hepatogastroenterology 1999;46: 2240–2245.
Luttges J, Feyerabend B, Buchelt T, Pacena M, Kloppel G: The mucin profile of noninvasive and invasive mucinous cystic neoplasms of the pancreas. Am J Surg Pathol 2002;26:466–471.
Kohno N: Serum marker KL-6/MUC1 for the diagnosis and management of interstitial pneumonitis. J Med Invest 1999;46: 151–158.
Takaishi H, Ohara S, Hotta K, et al: Circulating autoantibodies against purified colonic mucin in ulcerative colitis. J Gastroenterol 2000;35: 20–27.
Hinoda Y, Nakagawa N, Nakamura H, et al: Detection of a circulating antibody against a peptide epitope on a mucin core protein, MUC1, in ulcerative colitis. Immunol Lett 1993;35:163–168.
Melin A, Sparen P, Persson I, Bergqvist A: Endometriosis and the risk of cancer with special emphasis on ovarian cancer. Hum Reprod 2006;21:1237–1242.
Prowse AH, Manek S, Varma R, et al: Molecular genetic evidence that endometriosis is a precursor of ovarian cancer. Int J Cancer 2006;119:556–562.
Vigano P, Somigliana E, Chiodo I, Abbiati A, Vercellini P: Molecular mechanisms and biological plausibility underlying the malignant transformation of endometriosis: a critical analysis. Hum Repreod Update 2006;12: 77–89.
Yoshikawa H, Jimbo H, Okada S, et al: Prevalence of endometriosis in ovarian cancer. Gynecol Obstet Invest 2000;50 (Suppl 1): 11–17.
Ogawa S, Kaku T, Amada S, et al: Ovarian endometriosis associated with ovarian carcinoma: a clinicopathological and immunohistochemical study. Gynecol Oncol 2000;77:298–304.
Ness RB: En dometriosis and ovarian cancer: thoughts on shared pathophysiology. Am J Obstet Gynecol 2003;189: 280–294.
Brayman M, Thathiah A, Carson DD: MUC1: a multifunctional cell surface component of reproductive tissue epithelia. Reprod Biol Endocrinol 2004;2: 4.
Schenken RS, Williams RF, Hodgen GD: Experimental endometriosis in monkeys. Ann NY Acad Sci 1991;622: 242–255.
Schenken RS, Asch RH: Surgical induction of endometriosis in the rabbit: effects on fertility and concentrations of peritoneal fluid prostaglandins. Fertil Steril 1980;34: 581–587.
Awwad JT, Sayegh RA, Tao XJ, Hassan T, Awwad ST, Isaacson K: The SCID mouse: an experimental model for endometriosis. Hum Reprod 1999;14: 3107–3111.
Sato N, Tsunoda H, Nishida M, et al: Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary. Cancer Res 2000;60: 7052–7056.
Lesche R, Groszer M, Gao J, et al: Cre/loxP-mediated inactivation of the murine Pten tumor suppressor gene. Genesis 2002;32:148–149.
Dinulescu DM, Ince TA, Quade BJ,, Shafer SA, Crowley D, Jacks T: Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer. Nat Med 2005;11: 63–70.
Vlad AM, Kettel JC, Alajez NM, Carlos CA, Finn OJ: MUC1 immunobiology: from discovery to clinical applications. Adv Immunol 2004;82: 249–293.
Vlad AM, Muller S, Cudic M, et al: Complex carbohydrates are not removed during processing of glycoproteins by dendritic cells: processing of tumor antigen MUC1 glycopeptides for presentation to major histocompatibility complex class II-restricted T cells. J Exp Med 2002;196: 1435–1446.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vlad, A.M., Diaconu, I. & Gantt, K.R. MUC1 in endometriosis and ovarian cancer. Immunol Res 36, 229–236 (2006). https://doi.org/10.1385/IR:36:1:229
Issue Date:
DOI: https://doi.org/10.1385/IR:36:1:229